Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ishan Roy

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Biorxiv : the Preprint Server for Biology|November 28, 2023
Gait speed is a biomarker of cancer-associated cachexia decline and recoveryIshan Roy, Ben Binder-Markey, Danielle Sychowski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinomaIshan Roy, Kathleen A Boyle, Emily P Vonderhaar, et al.
Cancer Research|September 3, 2015
Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic SignalingIshan Roy, Donna M McAllister, Egal Gorse, et al.
Science Advances|March 5, 2025
Immunomodulatory role of the stem cell circadian clock in muscle repairPei Zhu, Eric M Pfrender, Adam W T Steffeck, et al.
Neuro-Oncology Advances|July 24, 2025
Natural language processing algorithms identify wild-type isocitrate dehydrogenase gliomas in electronic health recordsNoah Forrest, Vijeeth Guggilla, April Bell, et al.
Blood Advances|July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and EfficacyOluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Science Signaling|March 23, 2017
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activationJoshua J Ziarek, Andrew B Kleist, Nir London, et al.
Cancer Research|August 31, 2014
CXM: a new tool for mapping breast cancer risk in the tumor microenvironmentMichael J Flister, Bradley T Endres, Nathan Rudemiller, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Biorxiv : the Preprint Server for Biology|November 28, 2023
Gait speed is a biomarker of cancer-associated cachexia decline and recoveryIshan Roy, Ben Binder-Markey, Danielle Sychowski, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|January 17, 2017
Cancer cell chemokines direct chemotaxis of activated stellate cells in pancreatic ductal adenocarcinomaIshan Roy, Kathleen A Boyle, Emily P Vonderhaar, et al.
Cancer Research|September 3, 2015
Pancreatic Cancer Cell Migration and Metastasis Is Regulated by Chemokine-Biased Agonism and Bioenergetic SignalingIshan Roy, Donna M McAllister, Egal Gorse, et al.
Science Advances|March 5, 2025
Immunomodulatory role of the stem cell circadian clock in muscle repairPei Zhu, Eric M Pfrender, Adam W T Steffeck, et al.
Neuro-Oncology Advances|July 24, 2025
Natural language processing algorithms identify wild-type isocitrate dehydrogenase gliomas in electronic health recordsNoah Forrest, Vijeeth Guggilla, April Bell, et al.
Blood Advances|July 24, 2025
Nivolumab in Combination with R-CHOP for Treatment-Naïve Diffuse Large B-Cell Lymphoma: An Evaluation of Safety and EfficacyOluwatobi Odetola, Shuo Ma, Jane N Winter, et al.
Brain, Behavior, & Immunity - Health|April 4, 2022
A systematic review of pharmacologic treatment efficacy for depression in older patients with cancerErik E Rabin, Miri Kim, Andreas Mozny, et al.
Science Signaling|March 23, 2017
Structural basis for chemokine recognition by a G protein-coupled receptor and implications for receptor activationJoshua J Ziarek, Andrew B Kleist, Nir London, et al.
Cancer Research|August 31, 2014
CXM: a new tool for mapping breast cancer risk in the tumor microenvironmentMichael J Flister, Bradley T Endres, Nathan Rudemiller, et al.
Blood Advances|March 18, 2024
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapyMegan Melody, Narendranath Epperla, Geoffrey Shouse, et al.
Pageof 5